EKF Diagnostics HoldingsLSE:EKF +0.75%52 Interest Coverage is 32.00 as of Dec. 2025, which is 45% below its 10-year median of 57.83. GuruFocus rates LSE:EKF with a GF Score™ of 52/100 and a GF Value™ of £0.28 (Fairly Valued). The stock has 4 warning signs investors should review. Among 466 Medical Devices & Instruments companies, EKF Diagnostics Holdings ranks better than 65.67% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. EKF Diagnostics Holdings's
Operating Income
for the
six
months ended in Dec. 2025 was £3.39 Mil. EKF Diagnostics Holdings's Interest Expense for the
six
months ended in Dec. 2025 was £-0.11 Mil.
EKF Diagnostics Holdings's interest coverage for the quarter that ended in Dec. 2025 was 32.00.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for EKF Diagnostics Holdings's Interest Coverage or its related term are showing as below:
LSE:EKF'
s Interest Coverage Range Over the Past 10 Years
Min: 17.45 Med: 57.83 Max: 348.54
Current: 45.31
LSE:EKF's Interest Coverage is ranked better than 65.67% of 466
companies
in the Medical Devices & Instruments industry
Industry Median: 15.875
vs LSE:EKF: 45.31
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
EKF Diagnostics Holdings Interest Coverage Related Terms
EKF Diagnostics Holdings Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
LSE:EKF vs ABT, SYK, MDT: Interest Coverage Comparison
For the Medical Devices subindustry, EKF Diagnostics Holdings's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EKF Diagnostics Holdings Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, EKF Diagnostics Holdings's Interest Coverage distribution charts can be found below:
* The bar in red indicates where EKF Diagnostics Holdings's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EKF Diagnostics Holdings (LSE:EKF) has a Interest Coverage of 32.00 as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on EKF Diagnostics Holdings and its competitors. This is 45% below median its historical median of 57.83. Over the past decade, EKF Diagnostics Holdings' Interest Coverage has ranged from 17.45 to 348.54. According to the industry distribution chart, EKF Diagnostics Holdings ranks #160 out of 466 companies in the Medical Devices & Instruments industry, placing it in the top 34.3%.
Is EKF Diagnostics Holdings' Interest Coverage too high?
EKF Diagnostics Holdings' current Interest Coverage of 32.00 is 45% below median its 10-year median of 57.83. Over the past 10 years, this metric has ranged from a low of 17.45 to a high of 348.54. The Medical Devices & Instruments industry median Interest Coverage is 15.88. EKF Diagnostics Holdings' value of 32.00 is 101.6% above this industry median. Based on the distribution chart, EKF Diagnostics Holdings ranks #160 out of 466 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, EKF Diagnostics Holdings has a GF Score™ of 52/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does EKF Diagnostics Holdings' Interest Coverage compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, EKF Diagnostics Holdings ranks #160 out of 466 companies for Interest Coverage. This puts EKF Diagnostics Holdings in the upper half of its industry. The industry median Interest Coverage is 15.88. EKF Diagnostics Holdings' value of 32.00 is 101.6% above this benchmark. Historically, EKF Diagnostics Holdings' own Interest Coverage has ranged from 17.45 to 348.54 over the past decade. While the company's 10-year median is 57.83 vs. the industry median of 15.88, EKF Diagnostics Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 15.88, based on 466 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EKF Diagnostics Holdings's current Interest Coverage of 32.00 is 101.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on EKF Diagnostics Holdings and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 15.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EKF Diagnostics Holdings's current Interest Coverage is 32.00, which is 45% below median its own 10-year median of 57.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EKF Diagnostics Holdings stock overvalued right now?
Based on GuruFocus' analysis, EKF Diagnostics Holdings (LSE:EKF) is currently considered Fairly Valued. The stock's GF Value™ is £0.28, compared to a current price of £0.27 — trading 3.6% below its estimated fair value. The current Interest Coverage is 32.00, which is 45% below median its 10-year median of 57.83 and 101.6% above the Medical Devices & Instruments industry median of 15.88. EKF Diagnostics Holdings' overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For EKF Diagnostics Holdings (LSE:EKF), the current Interest Coverage is 32.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EKF Diagnostics Holdings (LSE:EKF) Overvalued in 2026?
Based on GuruFocus' analysis, EKF Diagnostics Holdings stock appears to be undervalued.
The current stock price of £0.27 is trading 3.6% below its estimated GF Value™ of £0.28.
GuruFocus considers EKF Diagnostics Holdings to be Fairly Valued.
Key valuation signals for LSE:EKF:
Interest Coverage: 32.00 (45% below median its 10-year median of 57.83)
GF Value™: £0.28 vs. price of £0.27 (3.6% below fair value)
Industry Position: 101.6% above the Medical Devices & Instruments median (#160 of 466)
No single metric tells the full story. See the LSE:EKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EKF Diagnostics Holdings PLC is engaged in development, manufacture and supply of products and services into the in-vitro diagnostic (IVD) market place. The Group has presence in the UK, USA, Germany, and Russia, and sells throughout the world including Europe, the Middle East, the Americas, Asia, and Africa. It derive their revenue from the manufacture and sale of medical diagnostic equipment and reagents. Other services include the servicing and distribution of third party company products under separate distribution agreements.
52GF Score
Get the complete analysis for LSE:EKF
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:EKF has been successfully added to your 
